Valeant Canada
Valeant Canada develops, manufactures, and markets a broad range of innovative pharmaceutical and medical device products, primarily in the areas of dermatology, eye health, cardio-metabolic, and neurology. We proudly employee approximately 1000 employees, at our two advanced manufacturing facilities in Steinbach, Manitoba, and Laval, Quebec, global head quarters based in Laval, and Bausch + Lomb administrative offices based in Vaughan, Ontario and in field forces across the country
Conference Objective
Support Canada's life sciences ecosystem as a trusted health care partner. Actively participate in discussions to advance Canada's role as a health innovator that provides optimal access to innovative treatments that improve the lives of patients.
Partnering Objective
Communicate and partner with Canadian health care leaders to advance Canada's role as an innovator and innovation adopter. Promote Valeant Canada's values of quality health care outcomes, understanding the needs of customers and patients through customer focus, researching and developing innovations for patients, delivering value through efficiency, and supporting our employees who come to work each day focused on improving people’s lives through our health care products
Delegate Contacts
Richard Lajoie was born in Shawinigan, Québec and left after college to pursue his academic and professional life across Canada, United-States and Europe. He has been recognized over the last 15 years as an inspirational and creative leader with a strong capacity to build high performing teams. Richard is President of Valeant Canada since June 2017 and joined the company in 2013 as Vice President of the Pharma Business Unit. He has lead innovative business model transformations, many new launches and completed successful business development deals
Martin Barbeau leads the Canadian market access, Health Economics and Outcomes (HEOR), external affairs and corporate communications teams from Laval Quebec and is also a member of the Valeant Canada operating committee leadership team. Mr. Barbeau is responsible for driving the market access strategy in partnership with governments and private payers to create value for patients by seeking optimal reimbursement and access to the company’s products
Rosie leads the national medical device market access and government affairs Bausch + Lomb portfolio, is a member of the Bausch + Lomb operations committee, and provides leadership private payer and advocacy support for Valeant Canada prescription products